Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Paramount Bed Holdings Co., Ltd. (7817:JPX), powered by AI.
Paramount Bed Holdings Co., Ltd. is currently trading at ¥3,515. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Paramount Bed Holdings Co., Ltd. on Alpha Lenz.
Paramount Bed Holdings Co., Ltd.'s P/E ratio is 22.1.
“Paramount Bed Holdings Co., Ltd. trades at a P/E of 22.1 (fair value) with modest ROE of 6.6%.”
Ask for details →Paramount Bed Holdings Co., Ltd. is a prominent entity in the healthcare equipment industry, primarily specializing in the manufacturing and distribution of hospital beds and related products. Its core function is to provide ergonomic, safe, and technologically advanced solutions that enhance patient care and comfort. Paramount Bed operates within the healthcare and medical facilities sector, focusing on hospitals, nursing homes, and other care institutions worldwide. The company is known for its innovative approaches in bedding systems, incorporating smart features like bed sensors and adjustable components to support patient monitoring and reduce caregiver workload. Paramount Bed's products are designed to cater to various healthcare needs, from basic ward setups to specialized intensive care units. As a leader in the market, it plays a crucial role in improving healthcare infrastructure and patient management by offering high-quality, reliable, and sustainable products. With a global footprint, Paramount Bed Holdings Co., Ltd. significantly contributes to advancing healthcare delivery systems, thereby playing a vital part in the overall healthcare and medical equipment market.
“Paramount Bed Holdings Co., Ltd. trades at a P/E of 22.1 (fair value) with modest ROE of 6.6%.”
Ask for details →Paramount Bed Holdings Co., Ltd. (ticker: 7817) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 4,360 employees. Market cap is $200.5B.
The current price is 3,515 with a P/E ratio of 22.07x and P/B of 1.46x.
ROE is 6.65% and operating margin is 11.95%. Annual revenue is $108.6B.